Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Deoxycytidine → 5-Hydroxy-2'-deoxycytidine
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Deoxycytidine | HCID 13711 | — |
| 반응물 | Bromine | HCID 24408 | — |
| 반응물 | 5-Hydroxydeoxycytidine-3',5'-diphosphate | HCID 131719392 | — |
| 용매 | Water | HCID 962 | — |
| 생성물 | 5-Hydroxy-2'-deoxycytidine | HCID 477413 | — |
반응 단계
5-Hydroxydeoxycytidine is synthesized in a similar manner to the published procedure of Eaton et al. (Biochem. Biophys. Acta 319:281-287, 1973) for 5-hydroxydeoxycytidine-3',5'-diphosphate. Bromine is added to a cooled (0° C.) solution of 2'-deoxycytidine (available from Sigma Chemical Company) in water until the yellow color persists. The excess bromine is quenched with cyclohexene and 2,4,6-collidine is added. After 2 hours, the reaction mixture is washed with ether and evaporated to dryness under vacuum. The crude 5-hydroxydeoxycytidine is then purified by reversed-phase HPLC on an ULTRASPHERE C18 column (Phenomenex) using a linear gradient of 0%-20% B in A (solvent A: 0.1 M NH4OAc, solvent B: 50% CH3CN in 0.1 M NH4OAc).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US06132776 |
| 출처 데이터셋 | uspto-grants-2000_10 |
| ORD ID | ord-a7c45c77dfa64da1ae9d570882b17a14 |
| 출처 메모 | uspto-grants-2000_10 |